Lilly files six lawsuits in bid to shut down 'black market' for retatrutide

Reports

2

Domains carrying it

2

First reported

12 August 2026

Latest report

13 August 2026

◆ Sectors

◆ Where

United States

◆ Timeline

1. 12 August 2026Lilly files six lawsuits in bid to shut down 'black market' for retatrutidebiopharmadive.com
2. 13 August 2026Eli Lilly sues 6 companies over illegal retatrutide salesqz.com

◆ Connected developments

Situations Wire finds semantically close to this one. Proximity, not cause.

• Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official2 reports · 2 domains · 9 August 2026
• FDA panel to review popular peptides amid persistent consumer appetite13 reports · 12 domains · 31 July 2026
• Psychedelics Gain Momentum in Big Pharma2 reports · 2 domains · 10 August 2026
• Lawmakers urge FDA to enact new China policies after 3 gene therapy deaths5 reports · 4 domains · 3 September 2026
• Amgen submits new data to challenge FDA's proposal to withdraw Tavneos2 reports · 2 domains · 25 July 2026
• FDA panel votes to place popular peptide BPC-157 on compounding list10 reports · 9 domains · 28 July 2026

◆ Share

◆ Evidence

2 reports · 2 domains

• Eli Lilly sues 6 companies over illegal retatrutide salesqz.com · 13 August 2026
• Lilly files six lawsuits in bid to shut down 'black market' for retatrutidebiopharmadive.com · 12 August 2026